SUMMARY Isolated bovine adrenocortical cells were incubated with and without 3 ng/ml ACTH, with various concentrations (10-1000 .tg/ml) of either cimetidine or ranitidine. Cortisol, corticosterone, and deoxycorticosterone outputs were measured. Cimetidine and ranitidine at 320 and 1000 ,ug/ml inhibited ACTH-stimulated corticosterone and cortisol synthesis and cimetidine decreased basal cortisol synthesis. The inhibitory effects of cimetidine on cortisol synthesis were approximately 10 times greater than those of ranitidine. Cimetidine (1000 [tg/ml), but not ranitidine increased deoxycorticosterone synthesis by ACTH-stimulated cells, indicating inhibition of 11-hydroxylation in the adrenal steroidogenic pathway. Although doses of cimetidine and ranitidine which produce these in vitro effects are much greater than plasma concentrations in normal clinical use, they might be important in acutely ill patients given intravenous bolus injections of cimetidine, or if either antagonist were accumulated by the adrenal to produce high intracellular concentrations.
The imidazole H2 receptor antagonist, cimetidine, prolongs the half-life of many drugs which are normally oxidized by the liver,' -3 by inhibition of the microsomal cytochrome P450-dependent monooxygenase system. 4 Other imidazole drugs such as etomidate, ketoconazole and omeprazole (an inhibition of the gastric proton pump) have recently been shown to inhibit steroid synthesis by blocking cytochrome P450-dependent reactions in the adrenal cortex5-7 and it is possible that cimetidine inhibits adrenal steroidogenesis by a similar mechanism.
The dose related effects of cimetidine on basal and ACTH-stimulated cortisol, corticosterone, and deoxycorticosterone synthesis were compared with those of a non-imidazole H2-receptor antagonist, ranitidine, which does not interfere with hepatic metabolism of other drugs8 and shows little affinity for hepatic cytochrome P450. prepared from minced slices of the inner adrenal cortices of six bovine adrenals by collagenase digestion using the method of Kenyon et Basal cortisol synthesis was inhibited by cimetidine at concentrations from 100 ()g/ml (p<005) but not by ranitidine. Both cimetidine and ranitidine inhibited ACTH-stimulated cortisol synthesis. At concentrations of 320 and 1000 (tg/ml the effects of cimetidine were more marked than ranitidine (p<0).l). The concentration of drug required for The patterns of corticosterone inhibition with ranitidine and cimetidine were broadly similar to those of cortisol, although inhibitory effects of cimetidine at 320 ng/ml were not significantly different from ranitidine. Cimetidine at 1000 sg/ml inhibited ACTH-stimulated corticosterone synthesis more than ranitidine (p<005). IC50s for ACTHstimulated synthesis were 480 ig/ml for cimetidine and 600 sg/ml for ranitidine. vitro studies with isolated perfused zona glomerulosa cells using a concentration of 0 35 ig ranitidine/ml found no effect on ACTH-stimulated aldosterone synthesis but an increase in basal secretion and a much reduced angiotensin II response. 15 More recently, Sancho et al '1 have shown that 300 mg ranitidine/day for three days reduced plasma cortisol and aldosterone concentrations in sodium deplete, normal man. Perhaps differences both in the effects seen and concentration of drug required are related to the different species used in these studies.
The IC50 for inhibition of cortisol synthesis by cimetidine is only 100-fold greater than peak plasma concentrations in normal use. ' In summary, very high concentrations of cimetidine and ranitidine inhibit adrenal steroidogenesis in vitro. The effect is more marked for cimetidine than ranitidine as cimetidine inhibits the I1-hydroxylase in the steroidogenic pathway whereas ranitidine does not. Because ranitidine has been reported as being 10 times more potent than cimetidine as an inhibitor of the H,-receptor, cimetidine is more likely to have side effects on adrenocorticosteroid synthesis. These observations may be clinically important and merit further study.
